对α4β2尼古丁受体亚型的恩特异性正调制
Josue Gaona1, Pradip K Gadekar2, Khaldoun S Abdelwahed1
1Department of Pharmaceutical Sciences and Health Outcomes, The University of Texas at Tyler, Tyler, Texas 75799, United States.
ACS chemical neuroscience
|April 29, 2025
概括
研究人员开发了GAT2802,这是一种针对α4β2尼古丁乙胆受体 (nAChRs) 的选择性正调节器 (PAM). 这种化合物通过增强nAChR功能来治疗尼古丁成和认知障碍.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 尼古丁乙胆受体 (nAChRs),特别是α4β2亚型,对于认知功能和奖励途径至关重要.
- 阿尔法4β2 nAChRs的失调与尼古丁成和认知障碍有关,使它们成为关键的治疗点.
研究的目的:
- 为了合成,解析和药理学描述GAT2800,一种新型的正调节器 (PAM) 的alpha4beta2 nAChRs.
- 评估GAT2800的反体及其活性,选择性和神经系统疾病中的潜在治疗应用.
主要方法:
- GAT2800的合成和立体化学分辨率以分离其S-和R-反体 (GAT2801和GAT2802).
- 使用两电极电压记录在表达不同nAChR亚型的Xenopus卵细胞中的药理学评估.
- 用于配置确认,计算对接和突变分析的X射线晶体学,以确定结合点和选择性决定因素.
- 在HEK细胞中的体外安全性评估和在斑马鱼幼虫中的体外发育毒性研究.
主要成果:
- 鉴定出GAT2802,R-enantiomer,是高灵敏度 (HS) 和低灵敏度 (LS) 的α4β2 nAChR异型的强有力的PAM,EC50值约为0.8-1μM.
- GAT2802在HS alpha4beta2 nAChRs中显示出乙胆引起的电流的显著增强,而在含有alpha3的nAChR中活动最小.
- 突变分析发现alpha4Cys233对GAT2802对含有alpha4的nAChRs的选择性至关重要.
- 在高达100微米的度下,GAT2802在斑马鱼中表现出微不足道的细胞毒性和没有显著的发育影响.
结论:
- GAT2802是一种高度选择性和强大的α4β2 nAChRs的阳性全调节器.
- 其有利的安全性和特定的作用机制使其成为开发用于治疗尼古丁成和认知障碍的新疗法的有希望的化合物.
- 对GAT2802的进一步研究可能为针对nAChR相关的神经疾病的新疗法铺平道路.
相关概念视频
Cholinergic Receptors: Nicotinic
2.1K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.1K
Adrenergic Receptors: ɑ Subtype
1.4K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.4K
Adrenergic Receptors: β Subtype
1.5K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.5K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
784
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
784
Allosteric Regulation
57.4K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
828
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
828


